This is the accepted manuscript version of the work published in its final form as Giron, L. B., & Abdel-Mohsen, M. (2022). Viral and Host Biomarkers of HIV Remission Post Treatment Interruption. Current HIV/AIDS Reports, 19(3), 217-233. https://doi.org/10.1007/s11904-022-00607-z Deposited by shareyourpaper.org and openaccessbutton.org. We've taken reasonable steps to ensure this content doesn't violate copyright. However, if you think it does you can request a takedown by emailing help@openaccessbutton.org
Objective(s): An HIV cure will impose aviraemia that is sustained following the withdrawal of antire...
Background: HIV posttreatment controllers are rare individuals who start antiretroviral therapy (ART...
HIV posttreatment controllers (PTCs) represent a natural model of sustained HIV remission, but they ...
This is the accepted manuscript version of the work published in its final form as Castillo‐Mancilla...
BACKGROUND: Validated biomarkers to evaluate HIV-1 cure strategies are currently lacking, therefore ...
This is the accepted manuscript version of the work published in its final form as Ismail, S. D., Ri...
This is the accepted manuscript version of the work published in its final form as Wand, Handan; Moo...
Therapeutic strategies aimed at achieving antiretroviral therapy (ART)-free HIV remission in infecte...
PURPOSE OF REVIEW: To summarize the current status and highlight recent findings on predictive bioma...
In HIV-infected patients, combination antiretroviral therapy (cART) during HIV-1 infection potently ...
Therapeutic strategies aimed at achieving antiretroviral therapy (ART)-free HIV remission in infecte...
In HIV-infected patients, combination antiretroviral therapy (cART) during HIV-1 infection potently ...
This is the accepted manuscript version of the work published in its final form as Moodie, Z., Dintw...
Introduction: Viral remission after analytical treatment interruption (ATI), termed post-treatment c...
Purpose of review The aim of the current review is to explore the evidence around virological remiss...
Objective(s): An HIV cure will impose aviraemia that is sustained following the withdrawal of antire...
Background: HIV posttreatment controllers are rare individuals who start antiretroviral therapy (ART...
HIV posttreatment controllers (PTCs) represent a natural model of sustained HIV remission, but they ...
This is the accepted manuscript version of the work published in its final form as Castillo‐Mancilla...
BACKGROUND: Validated biomarkers to evaluate HIV-1 cure strategies are currently lacking, therefore ...
This is the accepted manuscript version of the work published in its final form as Ismail, S. D., Ri...
This is the accepted manuscript version of the work published in its final form as Wand, Handan; Moo...
Therapeutic strategies aimed at achieving antiretroviral therapy (ART)-free HIV remission in infecte...
PURPOSE OF REVIEW: To summarize the current status and highlight recent findings on predictive bioma...
In HIV-infected patients, combination antiretroviral therapy (cART) during HIV-1 infection potently ...
Therapeutic strategies aimed at achieving antiretroviral therapy (ART)-free HIV remission in infecte...
In HIV-infected patients, combination antiretroviral therapy (cART) during HIV-1 infection potently ...
This is the accepted manuscript version of the work published in its final form as Moodie, Z., Dintw...
Introduction: Viral remission after analytical treatment interruption (ATI), termed post-treatment c...
Purpose of review The aim of the current review is to explore the evidence around virological remiss...
Objective(s): An HIV cure will impose aviraemia that is sustained following the withdrawal of antire...
Background: HIV posttreatment controllers are rare individuals who start antiretroviral therapy (ART...
HIV posttreatment controllers (PTCs) represent a natural model of sustained HIV remission, but they ...